Activated BCR signaling contributes to the development of B-cell malignancies (23) and plays a role in the pathobiology of other hematologic malignancies such as chronic lymphocytic leukemia (CLL) (24). Here, BCR is linked to B-cell chronic lymphocytic leukemia.